| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 06/10/2004 | CA2503246A1 Compositions and methods for diagnosing and treating mood disorders |
| 06/10/2004 | CA2501168A1 Recombinant poxvirus comprising at least two cowpox ati promoters |
| 06/10/2004 | CA2485950A1 Methods for cohort selection and longevity studies |
| 06/09/2004 | EP1426443A1 Novel human bmcc1 gene |
| 06/09/2004 | EP1426044A1 Use of esters of L-carnitine or alkanoyl L-carnitines as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 06/09/2004 | EP1426021A1 Implantable system with drug eluting cells for on-demand local drug delivery |
| 06/09/2004 | EP1425580A2 Lymphatic endothelial cells materials and methods |
| 06/09/2004 | EP1425413A2 Genes overexpressed in prostate disorders as diagnostic and therapeutic targets |
| 06/09/2004 | EP1425402A2 Improvement of gene expression in vectors |
| 06/09/2004 | EP1425400A2 Method for producing transgenic animals |
| 06/09/2004 | EP1425399A2 Combinatorial methods for inducing cancer cell death |
| 06/09/2004 | EP1425391A1 Therapeutic vaccination method, mutated peptides of hiv reverse transcriptase and their use for vaccination and diagnostic purposes |
| 06/09/2004 | EP1425390A2 Materials and methods to promote repair of nerve tissue |
| 06/09/2004 | EP1425305A1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses |
| 06/09/2004 | EP1425289A2 Novel nucleic acid and polypeptide molecules |
| 06/09/2004 | EP1425046A2 Wild-type ras as a cancer therapeutic agent |
| 06/09/2004 | EP1425045A1 Adenoviral vector and related system and methods of making and use |
| 06/09/2004 | EP1425036A2 Virus coat protein/receptor chimeras and methods of use |
| 06/09/2004 | EP1425035A1 Use of biologically active hiv-1 tat, fragments or derivatives thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 06/09/2004 | EP1425028A2 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 06/09/2004 | EP1424998A1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 06/09/2004 | EP1424897A2 Compositions and methods for treatment of cancer |
| 06/09/2004 | EP1424896A1 Method for expression of small rna molecules within a cell |
| 06/09/2004 | EP1424895A2 Method for expression of small antiviral rna molecules within a cell |
| 06/09/2004 | EP1424894A2 Inhibition of pathological angiogenesis in vivo |
| 06/09/2004 | EP1267917A4 Angiogenic onchocerca volvulus proteins and uses thereof |
| 06/09/2004 | EP1263449A4 Induction of beta cell differentiation in human cells by stimulation of the glp-1 receptor |
| 06/09/2004 | EP0753053B1 ALPHAVIRUS cDNA VECTORS |
| 06/09/2004 | CN1152962C Antiangiogenic peptides derived from plasminogen, its coded polynucleotide and method of inhibiting vascularization |
| 06/08/2004 | US6747187 Knockout mouse for the tumor suppressor gene ANX7 |
| 06/08/2004 | US6747133 Antibodies against the tumor suppressor gene ING1 |
| 06/08/2004 | US6747014 For therapy of inflammatory bowel disorder |
| 06/08/2004 | US6747013 Such as rheumatoid arthritis; gene therapy, such as to replace a defective apoptotic gene, to cells in the affected area |
| 06/08/2004 | US6747005 Determining importin alpha activities in presence and absence of camp-response element binding protein which acetylates importin alpha to determine effect on activities, comparing effect in presence and absence of test compound |
| 06/08/2004 | US6747004 Contacting embryonic forebrain cells in vitro with amount of endometrial bleeding associated factor protein having specified amino acid sequence effective to induce proliferation of forebrain cells |
| 06/08/2004 | US6746869 Electrospraying apparatus and method for coating particles |
| 06/08/2004 | US6746868 Chemical modification of DNA using peptide nucleic acid conjugates |
| 06/08/2004 | US6746865 Nucleic acids encoding for endostatin protein |
| 06/08/2004 | US6746441 Applying multiple series of three step (collection, electro-poration, electrophoresis) pulses to cell |
| 06/08/2004 | CA2023888C Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes |
| 06/03/2004 | WO2004046691A2 Uncaging devices |
| 06/03/2004 | WO2004046364A1 Adenoviral vectors for the transfer of specific genes into somatic cells |
| 06/03/2004 | WO2004046348A1 Methods, nucleic acid constructs and cells for treating neurodegenerative disorders |
| 06/03/2004 | WO2004046339A2 Caged sensors, regulators and compounds and uses thereof |
| 06/03/2004 | WO2004046324A2 Allele-targeted rna interference |
| 06/03/2004 | WO2004046320A2 METHODS AND COMPOSITIONS FOR REDUCING TARGET GENE EXPRESSION USING COCKTAILS OF siRNAS OR CONSTRUCTS EXPRESSING siRNAS |
| 06/03/2004 | WO2004046171A1 Novel functional peptide nucleic acid and process for producing the same |
| 06/03/2004 | WO2004046089A1 Novel functional peptide nucleic acid and process for producing the same |
| 06/03/2004 | WO2004045640A1 Gastrin compositions and formulations, and methods of use and preparation |
| 06/03/2004 | WO2004045638A1 Vanilloid receptor-2 ligands for treating anxiety or depression |
| 06/03/2004 | WO2004045563A2 Method of treatment of myocardial infarction |
| 06/03/2004 | WO2004045547A2 Rnai-based sensors, caged interfering rnas, and methods of use thereof |
| 06/03/2004 | WO2004045543A2 Functional and hyperfunctional sirna |
| 06/03/2004 | WO2004045527A2 Modulation of nima-related kinase 6 expression |
| 06/03/2004 | WO2004045513A2 Coronary artery disease treatment |
| 06/03/2004 | WO2004045496A2 Compositions and devices comprising or encoding the run x2 protein and method of use |
| 06/03/2004 | WO2004033723A3 Neurodegenerative disease-associated gene |
| 06/03/2004 | WO2004027033A3 Lentiviral vector-mediated gene transfer and uses thereof |
| 06/03/2004 | WO2004024904A3 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 06/03/2004 | WO2004022103A3 Foxp1 and uses thereof |
| 06/03/2004 | WO2004016283A3 Heteropolymeric compound comprising a scaffold, an adjuvant and an antigen, and its use |
| 06/03/2004 | WO2003102183A9 Pramyxovirus vectors encoding antibody and utilization thereof |
| 06/03/2004 | WO2003093476A9 Vector with modified protease-dependent tropism |
| 06/03/2004 | WO2003089619A3 Placental derived stem cells and uses thereof |
| 06/03/2004 | WO2003057159A9 Psoriasin expression by breast epithelial cells |
| 06/03/2004 | WO2003041128A3 Methods of promoting uptake and nuclear accumulation of polyamides in eukaryotic cells |
| 06/03/2004 | WO2003020739A3 Novel lna compositions and uses thereof |
| 06/03/2004 | WO2003006104A8 Lymphatic endothelial cells materials and methods |
| 06/03/2004 | WO2003000928A3 Methods for identification of cancer cell surface molecules and cancer specific promoters, and therapeutic uses thereof |
| 06/03/2004 | WO2002102846B1 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state |
| 06/03/2004 | WO2002097108A3 Antisense modulation of dual specific phosphatase 5 expression |
| 06/03/2004 | WO2002079402A9 Method of inhibiting cancerous cell proliferation using ras mutants of gdp-bound conformation |
| 06/03/2004 | WO1997035010A8 Chemokine alpha 2 |
| 06/03/2004 | US20040107453 Multipotent adult stem cells, sources thereof, methods of obtaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 06/03/2004 | US20040106864 Method of predicting stroke evolution utilising mri |
| 06/03/2004 | US20040106778 Interferon gamma-like protein |
| 06/03/2004 | US20040106775 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 06/03/2004 | US20040106568 Nucleic acid sequences containing unmethylated CpG dinucleotides that modulate an immune response including stimulating a Th1 pattern of immune activation, cytokine production, NK lytic activity, and B cell proliferation |
| 06/03/2004 | US20040106567 inhibiting expression of a gene in an extravascular mammalian cell by: a) injecting a naked polynucleotide into a blood vessel lumen; b) increasing permeability in the vessel; and, c) delivering the polynucleotide to an extravascular cell |
| 06/03/2004 | US20040106565 Gene expression, genome alteration and reporter expression in myofibroblasts and myofibroblast-like cells |
| 06/03/2004 | US20040106555 Neurogenin3 and production of pancreatic islet cells |
| 06/03/2004 | US20040106542 Compositions and methods for enhancing receptor-mediated cellular internalization |
| 06/03/2004 | US20040106539 Agents for the treatment of viral infections |
| 06/03/2004 | US20040106194 Genetically engineered gene transfer vector comprising mutiple viral serotype sequences and E4 region of preferential virus for use as transfer tool in gene therapy and vaccine preparation |
| 06/03/2004 | US20040106193 Novel adenoviral vector and methods for making and using the same |
| 06/03/2004 | US20040106181 Novel isoform of human camp-dependent protein kinase, calpha -s , localizes to sperm mid-piece and the use thereof |
| 06/03/2004 | US20040106174 Designing immunogens |
| 06/03/2004 | US20040106105 Vaccine |
| 06/03/2004 | US20040106101 System and method for quality control of a shipped neural cell culture on a microelectrode array |
| 06/03/2004 | US20040105894 Trace Metals synergized copper nucleotides and copper glycosides for anti-aging and antiviral compositions |
| 06/03/2004 | US20040105882 a membrane fusion liposome fused to Sendai virus for use in the treatment for arterial disorders or cartilage injuries |
| 06/03/2004 | US20040105847 Promoting Recovery from Damage to the Central Nervous System |
| 06/03/2004 | US20040105845 Delivering a genetic sequence to cells for gene therapy |
| 06/03/2004 | US20040105844 transfecting herpes simplex virus host cells with ampliicons by genetic engineering packaging a signal and expression vectors |
| 06/03/2004 | DE10254374A1 Adenovirale Vektoren zum Transfer von spezifischen Genen in Körperzellen Adenoviral vectors for the transfer of specific genes in somatic cells |
| 06/03/2004 | CA2506050A1 Methods, nucleic acid constructs and cells for treating neurodegenerative disorders |
| 06/03/2004 | CA2505721A1 Rnai-based sensors, caged interfering rnas, and methods of use thereof |
| 06/03/2004 | CA2505603A1 Caged sensors, regulators and compounds and uses thereof |
| 06/03/2004 | CA2505167A1 Gastrin compositions and formulations, and methods of use and preparation |
| 06/03/2004 | CA2501232A1 Coronary artery disease treatment |